NASDAQ: AEGR
Price:
33.96
Change:
+ 0.35
Day High:
34.00
Day Low:
33.65
Volume:
16,900
9:35 AM ET on Aug 1, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Overview

Stock price graph

Aegerion Pharmaceuticals is an emerging biopharmaceutical company focused on the development and commercialization of novel life-altering therapeutics for rare and often fatal diseases. 

Recent News

Germany's Federal Joint Committee (G-BA) grants LOJUXTA® (lomitapide) hard capsules a "no additional benefit" assessment based upon technical matters within the value dossier submitted. As expected, the decision is consistent with G-BA's preliminary assessment granted in March of this year. The Company plans to re-submit the dossier following the expiration of the decision on June 15, 2015.

View all »   RSSRecent Releases

Jul 30, 2014
Aegerion Pharmaceuticals Appoints Craig Fraser as Chief Operating Officer

Jul 29, 2014
Aegerion Pharmaceuticals Announces Second-Quarter 2014 Financial Results

Latest Annual Report

2013 Annual Report